Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products
The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers.
The New Hampshire legislature recently approved a proposal to legalize the personal use and possession of recreational cannabis. However, the bill does not include provisions for the regulated sale of marijuana. The legislation, known as HB 75 and sponsored by Representative Kevin Verville, was passed in the House through a voice vote in Thursday’s afternoon session.
The New Hampshire legislature recently approved a proposal to legalize the personal use and possession of recreational cannabis. However, the bill does not include provisions for the regulated sale of marijuana. The legislation, known as HB 75 and sponsored by Representative Kevin Verville, was passed in the House through a voice vote in Thursday’s afternoon session.
Reports of alleged fraudulent activity in cannabis testing labs have surfaced once again in New York’s recreational market, with claims that some vape oil cartridges are being labeled with cannabinoid levels exceeding 100%. Similar accusations of labs inflating THC levels to meet client demands and possibly altering data meant to ensure consumer safety have been raised in other states as well.
Constellation Brands shares sold off by 27% in reaction to its latest earnings report on weak wine and spirits sales, but its beers are strong but face tariffs
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.
The marijuana capital markets have encountered substantial hurdles in recent years. Investors who have been in the industry since 2019 have witnessed every phase of the market—from thrilling peaks to somber valleys.
Former U.S. President Joe Biden commuted the sentences of almost 2,500 inmates convicted of various non-violent drug offenses ( including marijuana ) during his last days in the Oval Office. Biden noted that with this last round of commutations, he has granted clemency to more Americans than any other president in U.S. history.
The marijuana industry experienced a sluggish pace of progress in 2024. Efforts to pass cannabis reform measures in Congress fell short, and the DEA delayed rescheduling cannabis as a recognized medicinal substance.
